0001441844-11-000041.txt : 20111004 0001441844-11-000041.hdr.sgml : 20111004 20111004172047 ACCESSION NUMBER: 0001441844-11-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111003 FILED AS OF DATE: 20111004 DATE AS OF CHANGE: 20111004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Mark Robert CENTRAL INDEX KEY: 0001331438 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 111124776 MAIL ADDRESS: STREET 1: 120 STATE STREET CITY: BROOKLYN STATE: NY ZIP: 11201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2011-10-03 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001331438 Baker Mark Robert 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 CEO Common Stock 2011-10-03 4 M 0 5124 4.624 A 42345 D Common Stock 2011-10-03 4 F 0 4666 5.44 D 37679 D ESPP (right to buy) 4.624 2011-10-03 4 M 0 5124 0 D 2011-10-01 2011-10-01 Common Stock 5124 0 D Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. By: Robert A. McKinney For: Mark R. Baker 2011-10-04